Skip to main content
Premium Trial:

Request an Annual Quote

Bina Technologies Adds $1.75M to Series B Financing Round

NEW YORK (GenomeWeb News) – Bioinformatics company Bina Technologies added $1.75 million to its Series B financing round, bringing the total raised in the round to $8 million, it said today.

Bina previously announced it raised $6.25 million in the round in March.

The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners and Jerry Yang, the former Yahoo! co-founder and CEO who now runs his own personal venture firm called AME Cloud Ventures.

The new funds, the Redwood City, Calif.-based company said, will help move Bina in its goal of becoming an integrated genomic analysis platform company to "unlock the potential of DNA-based medicine and biotechnology by delivering fast, accurate, and scalable genomic analysis."

Proceeds from the earlier $6.25 million raise went toward expanding Bina's development, marketing, sales, and support infrastructure.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.